Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital
Public ClinicalTrials.gov record NCT01298843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pharmacokinetics of a Single Dose of Ceftaroline Fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.
Study identification
- NCT ID
- NCT01298843
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2011
- Primary completion
- Jan 31, 2013
- Completion
- Jan 31, 2013
- Last update posted
- May 13, 2014
2011 – 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Phoenix | Arizona | 85008 | — |
| Investigational Site | Little Rock | Arkansas | 72202 | — |
| Investigational Site | Orange | California | 92868 | — |
| Investigational Site | San Diego | California | 92123 | — |
| Investigational Site | Indianapolis | Indiana | 46202 | — |
| Investigational Site | Louisville | Kentucky | 40202 | — |
| Investigational Site | Shreveport | Louisiana | 71113 | — |
| Investigational Site | Jackson | Mississippi | 39216 | — |
| Investigational Site | Omaha | Nebraska | 68198 | — |
| Investigational Site | Akron | Ohio | 44308 | — |
| Investigational Site | Cleveland | Ohio | 44106 | — |
| Investigational Site | Cleveland | Ohio | 44109 | — |
| Investigational site | Toledo | Ohio | 43606 | — |
| Investigational Site | Forth Worth | Texas | 76102 | — |
| Investigational Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01298843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2014 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01298843 live on ClinicalTrials.gov.